S100A16 is considered an oncogene and a prognostic marker of multiple cancers, including pancreatic cancer, colorectal cancer [9, 31, 32], especially lung adenocarcinomas and small-cell lung cancer [15, 33, 34]. This evidence concerns the gene S100A16 and familial pancreatic carcinoma.